Skip to content
Clinical Trials – home
Amsterdam UMC Stichting
Sponsor

Amsterdam UMC Stichting

The Netherlands De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands

About the sponsor

Amsterdam UMC conducts clinical research across a broad range of cancer types, with strong activity in pancreatic cancer, esophageal cancer, lung cancer, melanoma, breast cancer, bladder cancer, colorectal cancer, prostate cancer, and cholangiocarcinoma. Its studies also include advanced and metastatic disease, along with tumour-focused imaging and immunotherapy-related work.

  • Pancreatic cancer
  • Esophageal and esophagogastric cancer
  • Melanoma and skin cancer
  • Lung and bladder cancer
  • Tumour imaging and immunotherapy

Research interests extend to surgical oncology, perioperative treatment, and biomarker-driven approaches in gastrointestinal and solid tumours.

About Specializations

Amsterdam UMC Stichting runs clinical trials in conditions such as Non-small cell lung cancer, Multiple sclerosis, Post-acute COVID-19 syndrome, Crohn's disease, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

148 clinical trials

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:INDAPAMIDE HEMIHYDRATE
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Amsterdam UMC Stichting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Amsterdam UMC Stichting

Crohn's disease

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Methotrexate
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:Voclosporin
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Estradiol
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:SONLICROMANOL HYDROCHLORIDE
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tadalafil
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Guanabenz Acetate
  • Sponsor:Amsterdam UMC Stichting

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).